The Lobbying Register, read carefully Epicycle

Returns

Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.

Clear all

Showing returns filed by Pfizer .

Filed returns
28
match these filters
Matching filed returns per period 0 1 2 3 5 May–Aug 2020: 3 filed returns Jan–Apr 2022: 1 filed returns May–Aug 2022: 2 filed returns Sep–Dec 2022: 2 filed returns Jan–Apr 2023: 2 filed returns May–Aug 2023: 2 filed returns Jan–Apr 2024: 2 filed returns May–Aug 2024: 1 filed returns Sep–Dec 2024: 1 filed returns Jan–Apr 2025: 4 filed returns May–Aug 2025: 2 filed returns Jan–Apr 2026: 4 filed returns May–Aug 2026: 2 filed returns 2022 2023 2024 2025 2026
Filed returns per four-month period Click a column to list its returns.
PeriodRegistrantPolicy areaSubject, as filedOfficials namedLink
May–Aug 2026 Pfizer Health Discussion on the EU Biotech Act, access to medicines, innovation, and Ireland's life sciences policy environment, including opportunities to strengthen research, development, manufacturing, and the competitiveness of… (Public policy or programme) 3 On lobbying.ie
May–Aug 2026 Pfizer EU Affairs Ireland’s priorities for the 2026 Presidency of the Council of the European Union, including issues related to life sciences competitiveness (Public policy or programme) 5 On lobbying.ie
Jan–Apr 2026 Pfizer Health Ireland’s National Life Sciences Strategy (Public policy or programme) 1 On lobbying.ie
Jan–Apr 2026 Pfizer Health Ireland's medicine reimbursement system and access to new medicine (Matters involving public funds) 2 On lobbying.ie
Jan–Apr 2026 Pfizer EU Affairs Ireland’s priorities for the 2026 Presidency of the Council of the European Union, including issues related to life sciences competitiveness, pharmaceutical manufacturing, and EU-level health emergency preparedness (Public policy or programme) 3 On lobbying.ie
Jan–Apr 2026 Pfizer Health Expansion of the National Immunisation Programme to include RSV vaccination for older adults (Public policy or programme) 16 On lobbying.ie
May–Aug 2025 Pfizer Taxation Reform of R&D tax credit (Matters involving public funds) 2 On lobbying.ie
May–Aug 2025 Pfizer Trade Raise concern about the impact of potential tariffs and related geo-political issues related to the pharmaceutical industry and pricing of medicines globally (Public policy or programme) 11 On lobbying.ie
Jan–Apr 2025 Pfizer Health Expansion of the National Immunisation Programme to include RSV protection for infants and older adults (Public policy or programme) 6 On lobbying.ie
Jan–Apr 2025 Pfizer Trade Raise concern about the impact of potential tariffs on pharmaceutical manufacturing and supply of medicines to patients globally (Public policy or programme) 11 On lobbying.ie
Jan–Apr 2025 Pfizer EU Affairs EU Pharmaceutical Legislation proposals (Legislation) 7 On lobbying.ie
Jan–Apr 2025 Pfizer Health Ireland's medicine reimbursement system and funding for access to new medicines and vaccines (Matters involving public funds) 7 On lobbying.ie
Sep–Dec 2024 Pfizer EU Affairs EU Pharmaceutical Legislation proposals (Legislation) 6 On lobbying.ie
May–Aug 2024 Pfizer EU Affairs EU Pharmaceutical Legislation proposals (Legislation) 14 On lobbying.ie
Jan–Apr 2024 Pfizer EU Affairs EU Pharmaceutical Legislation proposals (Legislation) 9 On lobbying.ie
Jan–Apr 2024 Pfizer Health Ireland's medicine reimbursement system and access to new medicines and vaccines (Matters involving public funds) 14 On lobbying.ie
May–Aug 2023 Pfizer EU Affairs EU Pharmaceutical Legislation proposals (Legislation) 5 On lobbying.ie
May–Aug 2023 Pfizer Health Ireland's reimbursement system and funding for new medicines (Public policy or programme) 6 On lobbying.ie
Jan–Apr 2023 Pfizer Economic Development and Industry Pfizer recent 1.2 billion euro investment in Ireland operations creating 400-500 jobs (Public policy or programme) 13 On lobbying.ie
Jan–Apr 2023 Pfizer Health Ireland's pricing and reimbursement system and funding for new medicines (Public policy or programme) 14 On lobbying.ie
Sep–Dec 2022 Pfizer Energy and Natural Resources Potential energy shortages (Public policy or programme) 7 On lobbying.ie
Sep–Dec 2022 Pfizer Economic Development and Industry COVID-19 Trips waiver - vaccines and therapeutics (Public policy or programme) 7 On lobbying.ie
May–Aug 2022 Pfizer Budgetary matters Budget 2023 (Public policy or programme) 9 On lobbying.ie
May–Aug 2022 Pfizer Economic Development and Industry COVID-19 Trips waiver - vaccines and therapeutics (Public policy or programme) 17 On lobbying.ie
Jan–Apr 2022 Pfizer Economic Development and Industry Proposed COVID-19 Trips waiver (Public policy or programme) 12 On lobbying.ie
May–Aug 2020 Pfizer Economic Development and Industry Welcomed committment to corporation tax policy and a supportive environment for FDI as outlined in the Programme for Government (Public policy or programme) 28 On lobbying.ie
May–Aug 2020 Pfizer Health Highlighted discussions on extension of industry Supply Agreement and the importance of ensuring expenditure is efficently managed to ensure Irish patients can access innovative medicines; welcomed plans to progress the… (Public policy or programme) 28 On lobbying.ie
May–Aug 2020 Pfizer Health Provided information about Pfizer's research into a COVID-19 vaccine, meeting sought with MoH/DoH. (Public policy or programme) 29 On lobbying.ie

Policy areas in these returns

Public policy areaFiled returnsShareRelative to the largest
Health 11 39.3%
EU Affairs 7 25.0%
Economic Development and Industry 5 17.9%
Trade 2 7.1%
Budgetary matters 1 3.6%
Energy and Natural Resources 1 3.6%
Taxation 1 3.6%